Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarín A, Clotet B, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Teppler H, Nguyen B-Y, for the BENCHMRK Study Teams. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
The New England Journal of Medicine (N Engl J Med)
24 de julio 2008
Volumen 359 página(s) 355-65

Sin resumen.

ANTIRRETROVIRALES, ANTIVÍRICOS, ECC, ENSAYO CLÍNICO, HAART, HIV, INFECCIONES VÍRICAS, INHIBIDORES DE LA INTEGRASA, RALTEGRAVIR, RCT, SIDA, TARGA, TRATAMIENTO, VÍRICAS

Citas relacionadas 83711, 83714